22
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of a Nelfinavir- and Nevirapine-Containing Salvage Regimen

, , , , , & show all
Pages 7-12 | Published online: 29 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

José A. Pérez-Molina, Rosa Pérez Nr, Pilar Miralles, Jaime Cosín, Belén Padilla, Juan Berenguer & Emilio Bouza. (2001) Nelfinavir Plus Nevirapine Plus Two NRTIs As Salvage Therapy for HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment. HIV Clinical Trials 2:1, pages 1-5.
Read now

Articles from other publishers (7)

Vassil St. Georgiev. 2009. National Institute of Allergy and Infectious Diseases, NIH. National Institute of Allergy and Infectious Diseases, NIH 415 514 .
David Asmuth & Richard Pollard. 2006. Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Reverse Transcriptase Inhibitors in HIV/AIDS Therapy 303 344 .
E. A. Lilly, J. E. Cameron, K. V. Shetty, J. E. Leigh, S. Hager, K. M. McNulty, C. Cheeks, M. E. Hagensee & P. L. Fidel. (2005) Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. Oral Microbiology and Immunology 20:3, pages 154-162.
Crossref
Caroline M Perry, James E Frampton, Paul L McCormack, M Asif A Siddiqui & Risto S Cvetkovi??. (2005) Nelfinavir. Drugs 65:15, pages 2209-2244.
Crossref
Janet E. LeighKishore ShettyPaul L. FidelJr.Jr.. (2004) Oral Opportunistic Infections in HIV-Positive Individuals: Review and Role of Mucosal Immunity. AIDS Patient Care and STDs 18:8, pages 443-456.
Crossref
Zhijun Zhang, Robert Hamatake & Zhi Hong. (2016) Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under Development. Antiviral Chemistry and Chemotherapy 15:3, pages 121-134.
Crossref
E. Losina, R. Islam, A. C. Pollock, P. E. Sax, K. A. Freedberg & R. P. Walensky. (2004) Effectiveness of Antiretroviral Therapy after Protease Inhibitor Failure: An Analytic Overview. Clinical Infectious Diseases 38:11, pages 1613-1622.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.